Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 1984 Jul;45(1):139–142. doi: 10.1128/iai.45.1.139-142.1984

Protection against fatal Klebsiella pneumoniae burn wound sepsis by passive transfer of anticapsular polysaccharide.

S J Cryz Jr, E Fürer, R Germanier
PMCID: PMC263290  PMID: 6376353

Abstract

Klebsiella pneumoniae KP1-0 capsular polysaccharide (PS) was isolated from culture supernatants by coprecipitation with N-cetyl-N,N,N-trimethylammonium bromide. PS was composed primarily of carbohydrate and contained less than 1% (wt/wt) protein and nucleic acids. The protective capacity of passively transferred anti-PS was evaluated in a murine burn wound sepsis model. Anti-PS antibody was found to offer high levels of protection (P less than or equal to 0.02) against a low challenge dose of K. pneumoniae KP1-0. The 50% lethal dose for mice which received anti-PS antibody was increased from 10- to 40-fold over that for mice which received normal rabbit serum. Anti-PS antibody was found to be most effective at reducing mortality when administered before the challenge. In experiments designed to monitor the course of the infection, anti-PS was found to both delay the onset of bacteremia and reduce bacterial counts in the blood. Optimal protection against fatal burn wound sepsis was obtained by the use of a combined antibiotic and passive antibody therapy regimen.

Full text

PDF
139

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen J. R., Hightower A. W., Martin S. M., Dixon R. E. Secular trends in nosocomial infections: 1970-1979. Am J Med. 1981 Feb;70(2):389–392. doi: 10.1016/0002-9343(81)90777-4. [DOI] [PubMed] [Google Scholar]
  2. BAER H., EHRENWORTH L. The pathogenicity of Klebsiella pneumoniae for mice: the relationship to the quantity and rate of production of type-specific capsular polysaccharide. J Bacteriol. 1956 Nov;72(5):713–717. doi: 10.1128/jb.72.5.713-717.1956. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Casewell M. W., Phillips I. Aspects of the plasmid-mediated antibiotic resistance and epidemiology of Klebsiella species. Am J Med. 1981 Feb;70(2):459–462. doi: 10.1016/0002-9343(81)90788-9. [DOI] [PubMed] [Google Scholar]
  4. Christensen S. C., Korner B. An endemic caused by multiresistant klebsiella in an urological unit. Scand J Urol Nephrol. 1972;6(3):232–238. doi: 10.3109/00365597209132093. [DOI] [PubMed] [Google Scholar]
  5. Cooper J. M., Finlay-Jones J. J., Hill N. L., Rowley D. Local immunity to klebsiella pneumoniae in the lungs of mice. J Infect Dis. 1983 Feb;147(2):312–317. doi: 10.1093/infdis/147.2.312. [DOI] [PubMed] [Google Scholar]
  6. Cooper J. M., Rowley D. Resistance to Klebsiella pneumoniae and the importance of two bacterial antigens. Aust J Exp Biol Med Sci. 1982 Dec;60(6):629–641. doi: 10.1038/icb.1982.65. [DOI] [PubMed] [Google Scholar]
  7. Cross A., Allen J. R., Burke J., Ducel G., Harris A., John J., Johnson D., Lew M., MacMillan B., Meers P. Nosocomial infections due to Pseudomonas aeruginosa: review of recent trends. Rev Infect Dis. 1983 Nov-Dec;5 (Suppl 5):S837–S845. doi: 10.1093/clinids/5.supplement_5.s837. [DOI] [PubMed] [Google Scholar]
  8. Cryz S. J., Jr, Fürer E., Germanier R. Passive protection against Pseudomonas aeruginosa infection in an experimental leukopenic mouse model. Infect Immun. 1983 May;40(2):659–664. doi: 10.1128/iai.40.2.659-664.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Domenico P., Johanson W. G., Jr, Straus D. C. Lobar pneumonia in rats produced by clinical isolates of Klebsiella pneumoniae. Infect Immun. 1982 Jul;37(1):327–335. doi: 10.1128/iai.37.1.327-335.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fader R. C., Davis C. P. Effect of piliation on Klebsiella pneumoniae infection in rat bladders. Infect Immun. 1980 Nov;30(2):554–561. doi: 10.1128/iai.30.2.554-561.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Fournier J. M., Jolivet-Reynaud C., Riottot M. M., Jouin H. Murine immunoprotective activity of Klebsiella pneumoniae cell surface preparations: comparative study with ribosomal preparations. Infect Immun. 1981 May;32(2):420–426. doi: 10.1128/iai.32.2.420-426.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Graybill J. R., Marshall L. W., Charache P., Wallace C. K., Melvin V. B. Nosocomial pneumonia. A continuing major problem. Am Rev Respir Dis. 1973 Nov;108(5):1130–1140. doi: 10.1164/arrd.1973.108.5.1130. [DOI] [PubMed] [Google Scholar]
  13. Hill H. R., Hunt C. E., Matsen J. M. Nosocomial colonization with Klebsiella, type 26, in a neonatal intensive-care unit associated with an outbreak of sepsis, meningitis, and necrotizing enterocolitis. J Pediatr. 1974 Sep;85(3):415–419. doi: 10.1016/s0022-3476(74)80133-2. [DOI] [PubMed] [Google Scholar]
  14. Johanson W. G., Jr, Pierce A. K., Sanford J. P., Thomas G. D. Nosocomial respiratory infections with gram-negative bacilli. The significance of colonization of the respiratory tract. Ann Intern Med. 1972 Nov;77(5):701–706. doi: 10.7326/0003-4819-77-5-701. [DOI] [PubMed] [Google Scholar]
  15. Jones R. J., Roe E. A., Gupta J. L. Controlled trials of a polyvalent pseudomonas vaccine in burns. Lancet. 1979 Nov 10;2(8150):977–982. doi: 10.1016/s0140-6736(79)92559-5. [DOI] [PubMed] [Google Scholar]
  16. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  17. Lorian V., Topf B. Microbiology of nosocomial infections. Arch Intern Med. 1972 Jul;130(1):104–110. [PubMed] [Google Scholar]
  18. Mertz J. J., Scharer L., McClement J. H. A hospital outbreak of Klebsiella pneumonia from inhalation therapy with contaminated aerosol solutions. Am Rev Respir Dis. 1967 Mar;95(3):454–460. doi: 10.1164/arrd.1967.95.3.454. [DOI] [PubMed] [Google Scholar]
  19. Nakane P. K., Kawaoi A. Peroxidase-labeled antibody. A new method of conjugation. J Histochem Cytochem. 1974 Dec;22(12):1084–1091. doi: 10.1177/22.12.1084. [DOI] [PubMed] [Google Scholar]
  20. Nathan P., Holder I. A., MacMillan B. G. Burn wounds: microbiology, local host defenses, and current therapy. CRC Crit Rev Clin Lab Sci. 1973 Jul;4(1):61–100. doi: 10.3109/10408367309151684. [DOI] [PubMed] [Google Scholar]
  21. OSBORN M. J. STUDIES ON THE GRAM-NEGATIVE CELL WALL. I. EVIDENCE FOR THE ROLE OF 2-KETO- 3-DEOXYOCTONATE IN THE LIPOPOLYSACCHARIDE OF SALMONELLA TYPHIMURIUM. Proc Natl Acad Sci U S A. 1963 Sep;50:499–506. doi: 10.1073/pnas.50.3.499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Pollack M. Significance of circulating capsular antigen in Klebsiella infections. Infect Immun. 1976 Jun;13(6):1543–1548. doi: 10.1128/iai.13.6.1543-1548.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Pruitt B. A., Jr Infections caused by Pseudomonas species in patients with burns and in other surgical patients. J Infect Dis. 1974 Nov;130 (Suppl)(0):S8–13. doi: 10.1093/infdis/130.supplement.s8. [DOI] [PubMed] [Google Scholar]
  24. Riottot M. M., Fournier J. M., Jouin H. Direct evidence for the involvement of capsular polysaccharide in the immunoprotective activity of Klebsiella pneumoniae ribosomal preparations. Infect Immun. 1981 Jan;31(1):71–77. doi: 10.1128/iai.31.1.71-77.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Riottot M., Fournier J. M., Pillot J. Capsular serotypic specificity of the protection conferred on mice by Klebsiella pneumoniae ribosomal preparations. Infect Immun. 1979 May;24(2):476–482. doi: 10.1128/iai.24.2.476-482.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Thomas F. E., Jackson R. T., Melly A., Alford R. H. Sequential hospitalwide outbreaks of resistant Serratia and Klebsiella infections. Arch Intern Med. 1977 May;137(5):581–584. [PubMed] [Google Scholar]
  27. Wong K. H., Barrera O., Sutton A., May J., Hochstein D. H., Robbins J. D., Robbins J. B., Parkman P. D., Seligmann E. B., Jr Standardization and control of meningococcal vaccines, group A and group C polysaccharides. J Biol Stand. 1977;5(3):197–215. doi: 10.1016/s0092-1157(77)80005-x. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES